Tue.Dec 17, 2024

article thumbnail

STAT+: PBMs face scrutiny from all sides, and analyzing Marty Makary’s road to the FDA

STAT

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Congress nears spending deal with long-awaited PBM reforms Congress is on the edge of a deal that would reshape pharmacy benefit managers, extend telehealth access, and renew certain public health authorities.

Packaging 229
article thumbnail

Half of adults struggle to access trusted health information

The Pharmacist

Around half of adults in the UK struggle to access trusted health information, according to a new report. The study, published by the Patient Information Forum (PIF) and Ipsos,called Knowledge is Power, found that 53% of people felt they could trust the health information they found offline, with 45% saying they could trust the information […] The post Half of adults struggle to access trusted health information appeared first on The Pharmacist.

125
125
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: FDA deputy commissioner Namandjé Bumpus to leave agency

STAT

Namandjé Bumpus, principal deputy commissioner of the Food and Drug Administration, is leaving the agency. Commissioner Robert Califf shared the news with staff Tuesday morning, according to an email reviewed by STAT.

article thumbnail

B&R drives adaptive manufacturing solutions in pharma production

Express Pharma

Revolutionising pharma the adaptive way Pharmaceutical manufacturing is undergoing a transformative development, driven by innovative technologies that enable right-first time (RFT) production and adaptive scaling to meet changing demands. By embracing smart manufacturing, the industry is addressing numerous challenges, allowing consumers to receive life-saving drugs more quickly and sustainably.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Multi-sector pharmacist training no longer mandatory for 2026/27

The Pharmacist

Pharmacy employers will not have to offer multi-sector training placements in 2026/27, NHS England (NHSE) has announced. In a letter to the sector, chief pharmaceutical officer for England David Webb and NHSE director of education quality and reform Samantha Illingworth, said they were 'mindful of the current pressures faced by pharmacy teams and the broader […] The post Multi-sector pharmacist training no longer mandatory for 2026/27 appeared first on The Pharmacist.

114
114
article thumbnail

A biotech’s race to tackle the most severe hepatitis

PharmaVoice

Bluejay Therapeutics is one of just a handful of companies developing treatments for hepatitis D.

278
278

More Trending

article thumbnail

Yugal Sikri outlines 3 key trends defining India’s pharma growth in 2025

Express Pharma

India’s pharmaceutical industry, a global leader in generics, is poised for exponential growth. The sector is targeting a remarkable $130 billion by 2030 and a visionary $450 billion by 2047. Several key trends are shaping the industrys trajectory: Market consolidation: Strategic mergers and acquisitions, primarily backed by private equity, are reshaping the industry landscape.

article thumbnail

MindMed begins phase 3 study of MM120 for anxiety disorder

Pharma Times

First patient dosed in landmark trial for GAD treatment

136
136
article thumbnail

Schizophrenia market to reach $17 billion in 7MM by 2031, forecasts GlobalData

Express Pharma

The schizophrenia market across the seven major markets (7MM*) is poised to grow at a compound annual growth rate (CAGR) of 7.4 per cent from $8.4 billion in 2021 to $17.0 billion in 2031, driven by the anticipated introduction of 11 late-stage pipeline products during the forecast period, according to GlobalData. GlobalDatas latest report, Schizophrenia: Seven-Market Drug Forecast and Market Analysis Update, reveals that the late-stage pipeline products are expected to capture a significant po

article thumbnail

German cancer centre treats first patient with Elekta Evo

Pharma Times

New CT-guided radiotherapy system offers personalised cancer treatment

135
135
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Granules Pharmaceuticals gains U.S. FDA approval for Lisdexamfetamine Dimesylate chewable tablets

Express Pharma

Granules India, through its wholly-owned foreign subsidiary Granules Pharmaceuticals (GPI), has received approval from the U.S. Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Lisdexamfetamine Dimesylate Chewable Tablets. The product, available in strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg, is bioequivalent to Vyvanse Chewable Tablets by Takeda Pharmaceuticals USA.

109
109
article thumbnail

Maternal mortality trends remain dire — and researchers face an uphill battle to solve them

PharmaVoice

Rising maternal mortality, particularly among vulnerable populations, stems in part from a lack of research in pregnant women.

130
130
article thumbnail

Sanofi, Teva say study results show gut disease drug could be ‘best in class’

BioPharma Dive

Phase 2 results in inflammatory bowel disease hinted the therapy could be more potent than similar medicines from Merck and Roche, each of which were acquired in multibillion-dollar deals.

109
109
article thumbnail

Novo Nordisk invests $1.2bn in new Denmark facility

Pharmaceutical Technology

Construction has already begun on the Ozempic-producers new Denmark production facility and 40,000m2 warehouse.

105
105
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Teva, Sanofi score well with anti-TL1A drug in IBD test

pharmaphorum

Phase 2b results with Sanofi and Teva's duvakitug are exciting and warrant a swift move to phase 3 in inflammatory bowel disease, say the companies.

96
article thumbnail

Merck targets 2025 RSV season with antibody now under FDA review

BioPharma Dive

An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from respiratory syncytial virus.

94
article thumbnail

AbbVie acquires Roche immune drug spinout in $200 million deal

Outsourcing Pharma

AbbVie acquires Nimble Therapeutics in $200M deal to advance oral peptide therapies for autoimmune diseases.

article thumbnail

Study backs Closed Loop's drug+digital blood pressure plan

pharmaphorum

Closed Loop Medicine's smartphone app for blood pressure monitoring has shown proof-of-concept in the Cure-19 study.

75
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Nano drug delivery system heralds safer era for drug development

World Pharma News

A team of University of Melbourne researchers from the Caruso Nanoengineering Group has created an innovative drug delivery system with outstanding potential to improve drug development. The team has pioneered a drug delivery system that is a coordination network composed of only metal ions and biomolecules, known as metal-biomolecule network (MBN).

article thumbnail

Electronic Product Information Moves Forward in Europe

PharmaTech

A pilot program to explore creation and testing of ePIs in regulatory procedures shows positive results.

64
article thumbnail

CTO Europe 2024: keep the burden of trials away from patients, say experts

Pharmaceutical Technology

The two-day event included talks on subjects ranging from how to best utilise AI to how to build a stable CRO.

64
article thumbnail

Drug Channels News Roundup, December 2024: Crazy Medicare Reimbursements, Independents Grow (Really!), AFP Risks, Pharmacy History, GLP-1 Jokes, and Two Cool Dudes

Drug Channels

Happy New Year, everyone! Its been a huge year for Drug Channels Institute (DCI). In January, HMP Global acquired DCI. Thanks to our new friends at HMP, we will hold the Drug Channels Leadership Forum. This landmark event will take place in March 2025 in Miami. (If you havent done so yet, click here to request an invitation.) Once again, I thank you, dear readers, for welcoming Drug Channels into your inboxes, browsers, and apps.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

China NMPA approves MSD’s KEYTRUDA for stages of NSCLC

Pharmaceutical Technology

China National Medical Products Administration (NMPA) has approved MSDs KEYTRUDA for treating certain non-small cell lung cancer (NSCLC).

59
article thumbnail

Namandjé Bumpus, FDA’s No. 2 official, to depart agency at end of year

BioPharma Dive

Bumpus replaced agency veteran Janet Woodcock as principal deputy commissioner in February 2024. She was previously the FDA’s chief scientist.

57
article thumbnail

Biotech bounces back as venture funding grows $3.8m from 2023 to 2024YTD

Pharmaceutical Technology

However, caution persists:166 of 785 US venture-backed companies with an innovator drug in development have not raised capital since 2021.

59
article thumbnail

Pfizer predicts stability, to Wall Street’s relief

BioPharma Dive

The company forecast revenue next year will grow slightly versus this year, when excluding certain factors. “The uncertainty caused by COVID [is] mostly resolved,” its CFO said.

57
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

GSK’s lung cancer therapy gains EMA PRIME designation

Pharmaceutical Technology

GSKs GSK227 has gained Priority Medicines (PRIME) designation from the EMA for the treatment of relapsed ES-SCLC.

59
article thumbnail

Men With History of Cannabis Use Have Less Cognitive Decline From Early Adulthood to Late Midlife

Pharmacy Times

The investigators also find that age of initiation and frequent use were not associated with a greater age-related cognitive decline.

55
article thumbnail

The Dangerous Truth About Mail Order Pharmacies: Rising Costs and Hidden Risks

The Happy PharmD

Mail order pharmacies have exploded in popularity in recent years, but many pharmacists and patients are starting to notice something isnt quite right. The convenience of receiving prescriptions at home is appealing, but its coming at a hidden cost. Over the past decade, mail order pharmacy sales have more than doubled, growing from $86 billion to over $206 billion, yet the number of prescriptions filled through mail order only increased by 11%.

article thumbnail

Paxlovid’s Double-Edged Sword: Treating COVID-19 and the Risk of Viral Load Rebound

Pharmacy Times

The conversation of VLR has sparked a discussion as to whether or not other COVID-19 treatment agents are associated with a surge in symptoms and if so, how those agents compare with the rebound effect of nirmatrelvir/ritonavir.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.